(Q39954213)

English

Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

Enhancement of somatostatin-receptor-targeted (177)Lu-[DOTA(0)-Tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation (English)

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

1

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

author name string

Robert W Atcher

2

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

Jeffrey P Norenberg

4

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

publication date

1 August 2008

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

Nuclear Medicine and Biology

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

35

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

673-678

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

6

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

Yttrium-90 DOTATOC: first clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted radionuclide therapy for neuroendocrine tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptor radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal toxicity after radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation-induced up-regulation of somatostatin receptor expression in small cell lung cancer in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemical radiosensitizers for use in radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy as adjuvant treatment of gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Future chemoradiation strategies in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pancreatic cancer: current limitations, future possibilities

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and radiosensitization in human tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18678352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.NUCMEDBIO.2008.05.003

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6541001

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39954213&oldid=1880873746"